Mensur Salihovic

Mr. Mensur Salihovic

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MSMensur Salihovic
Mensur Salihovic
BRBoris Rijavec
Boris Rijavec
AMAnida Muratagic
Anida Muratagic
RBRok Blagus
Rok Blagus
UPUrska Puh
Urska Puh
Background and Objective. Knee osteoarthritis is a serious epidemiological problem that causes severe pain and impairs abilities. We investigated the effects of adductor canal blockade (ACB) on chronic osteoarthritis knee pain, motor function, and mobility. Methods. Seventy‐seven patients with chronic knee osteoarthritis pain received ultrasound‐guided ACB with 14 ml 0.25% levobupivacaine and 100 mcg clonidine. At baseline and 1 month after the blockade, we assessed maximal and minimal pain intensity in the knee using a numeric rating scale (NRS) and the Knee Injury and Osteoarthritis Outcome Score (KOOS). The range of motion in extension and flexion (ROMext and ROMflex) and quadriceps muscle strength of both knees (QS), Timed Up and Go Test (TUG), and 30‐Second Chair Stand Test (30CST) results were determined at baseline, 1 hour, 1 week, and 1 month after the blockade. Results. ACB with levobupivacaine and clonidine appeared to decrease pain severity (NRSmax 8.13 to 4.2, p < 0.001 and NRSmin 3.32 to 1.40, p < 0.001). Similarly, knee ROMext decreased from 3.90 preintervention to 2.89 postintervention at 1 month, p < 0.001; ROMflex decreased from 5.70 to 3.29, p < 0.001; TUG time decreased from 3.22 to 2.93, <0.001; QS increased from 18.43 to 22.77, p < 0.001; CST increased from 8.23 to 10.74, p < 0.001. The KOOS for pain (36.40 to 58.34), symptoms (52.55 to 64.32), activities of daily living functions (ADLs, 36.36 to 60.77), and quality of life (QoL, 17.87 to 30.97) also increased, all p < 0.001. Conclusion. ACB appeared to decrease pain and increase ambulation. If our preliminary results are reproducible in a planned randomized controlled trial, ACB could be a useful adjunctive pain therapy in patients with disabling pain due to knee OA.

24 May 2024 in EP Europace
Verified
Journal Article
Open access
PDF file
TKTine Prolič Kalinšek
Tine Prolič Kalinšek
MSMensur Salihovic
Mensur Salihovic
VPV Podlogar
V Podlogar
JSJ Stublar
J Stublar
JIJ Irsic
J Irsic
MJMatevž Jan
Matevž Jan
Introduction: Arrhythmic storm (AS) due to repetitive ventricular arrhythmias (VA) is a life-threatening condition that can be resistant to antiarrhythmic therapy. Sympathetic nervous system plays an important role in triggering and maintaining VA. Reducing sympathetic activity by percutaneous stellate ganglion blockade (SBG) may improve outcomes in treating AS. Purpose: To evaluate the effect of SBG on outcomes of AS. Methods: In this retrospective study, we analyzed 18 patients treated with SBG for AS from August 2017 to May 2022. All patient experienced VA while on antiarrhythmic drug therapy. SBG was performed under ultrasound guidance to avoid vascular structures. Either 0.75% levobupivacaine or 0.5% ropivacaine were applied to block the stellate ganglion after negative aspiration. The decision to perform unilateral or bilateral SBG was left to the operator. Results: The majority of patients were male (17/18, 94.4%), mean age was 61.8 ± 13.4 years, mean BMI 28.1 ± 5.39 kg/m2, mean LVEF was 34.4 ± 12.2%, majority had an ischemic cardiomyopathy (12/18, 66.7%). Half of the patients had monomorphic VA (9/18, 50.0%), the other half had polymorphic VA (9/18, 50.0%). Majority of patients were hemodynamically unstable (13/18, 72.2%) and more than a third had a cardiac arrest (7/18, 38.9%). Half of the patients had unilateral SBG (9/18, 50.0%), and the other half bilateral SBG (9/18, 50.0%). SBG was repeated in two patients (2/18, 11.1%). On the repeat procedure, both had bilateral SBG. There were 4 minor complications (4/18, 22.2%) and no major complications. Two patients had intermittent Horner’s syndrome, one had a small hematoma on the puncture site, and one had small hematoma in the mediastinum. All complications resolved on their own and did not require an intervention. In the 72 hours after SBG, 5 patients had a recurrence of VA (5/18, 27.8%). After the discharge, 6 patients also had a recurrence of VA (6/18, 44.4%). SBG significantly reduced mean number of VA episodes in the next 72 hours (12.3 ± 11.1 vs 4.3 ± 10.6; P=0.007) with a mean difference of 8.0 VA episodes (95% CI, 4.5 - 14.0; P=0.007) (Figure 1). One patient died due to recurrent VA leading to ischemic brain damage (1/18, 5.6%). Four patients died due to non-VA related causes (4/18, 22.2%). Two deaths were due to septic shock, the other two due to cardiogenic shock. Details of baseline characteristics and outcomes are in the Figure 2. Conclusion: SBG significantly reduces episodes of VA after failed antiarrhythmic drug therapy in patients presenting with AS.A before-after graph of VA after SBG.Baseline and outcomes table.

Verified
Journal Article
Open access
PDF file
BRBoris Rijavec
Boris Rijavec
MSMensur Salihovic
Mensur Salihovic
TMTomislav Mirković
Tomislav Mirković
Local anesthetics are widely used across local and regional anesthesia, pain medicine, emergency care, and dentistry. Their therapeutic effect is based mainly on reversible voltage-gated sodium channel inhibition, but toxicity is not limited to this mechanism. This narrative review integrates molecular evidence on systemic and tissue-specific local anesthetic toxicity. Bupivacaine remains the prototypical cardiotoxic agent, reflecting the convergence of high lipophilicity, persistent cardiac ion channel effects, myocardial accumulation, impaired mitochondrial bioenergetics, altered fatty acid metabolism, calcium dyshomeostasis, and membrane-level injury. Across experimental and translational models, local anesthetics may also induce broad cytotoxicity in various cell types. These effects are primarily concentration- and exposure time-dependent and are modified by route, tissue perfusion, local clearance, metabolic reserve, developmental or physiological vulnerability, and repair capacity. Current experimental, translational, and stem cell-based models provide mechanistic insight but cannot be interpreted as direct clinical dose equivalents. Future studies should link drug type, concentration, formulation, route, exposure duration, patient vulnerability, and tissue-specific outcomes to improve route-specific safety assessment.

1 January 2020 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
JKJurij Aleš Košir
Jurij Aleš Košir
MSMensur Salihovic
Mensur Salihovic
PSPrimož Sever
Primož Sever
JKjasna klen
jasna klen
Disseminated intravascular coagulation (DIC) is a blood clotting disorder that is characterized by intravascular thrombi formation and exhaustion of platelets and coagulation factors resulting in diffuse hemorrhage and multiple organ dysfunction. We present a case report of a previously healthy middle-aged patient who was treated by low anterior resection for rectal carcinoma and suddenly went into unexpected circulatory shock on the 7th postoperative day. Despite our resuscitation efforts, he succumbed to the disease. The postmortem examination showed findings consistent with DIC. The cause for DIC in this patient may be multifactorial. Sepsis, tumor-related factors and hereditary predisposition may have played a role. The role of blood components in treatment is not fully understood as they may worsen the inflammatory response. DIC can be the presenting sign of unrecognized sepsis and it can occur in all surgical patients. Even with prompt treatment, the disease can have a fatal course.